Back to companies

Evommune, Inc.

EVMNUSNYSEPharmaceuticals & Healthcare

Evommune, Inc.

Revenue
$13.0mn
YoY +85.7%
Operating income
-$81.1mn
FY2025
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API